Actinium Pharmaceuticals grants stock option to new employee
What happened
Actinium Pharmaceuticals announced an inducement equity award to a newly hired non-executive employee. The company granted the employee a non-qualified stock option to purchase 3,000 shares of common stock at an exercise price of $1.40 per share. The option has a ten-year term, with 28% of the shares vesting on the first anniversary of the grant date.
From prnewswire.com
Why it matters
The award is structured outside of the company's existing stock plan and is material to the employee's hiring. This action directly changes the company's equity structure and relates to talent acquisition costs.
Actinium Pharmaceuticals is a company that pioneers targeted radiotherapies designed to improve outcomes for patients with cancer.
From prnewswire.com
Who's involved
- companyThe company that granted the inducement stock option award
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- companySpeculative
The company might see changes in talent acquisition costs due to the equity award.
Keep exploring
The entities involved
-
company
legal entity representing an association of people, whether natural, legal or a mixture of both, with a specific objective